Treatment of Myelodysplastic Syndromes with Orally Administered l-β-Z)-Arabinofuranosylcytosine-5’-Stearylphosphate
暂无分享，去创建一个
N. Tatsumi | H. Mizoguchi | K. Kimura | R. Ohno | Kazumasa Yamada | K. Takatsuki | M. Kosaka | I. Kimura | T. Masaoka | M. Hirano | K. Toyama | T. Ohshima | S. Hashimoto | Tohru Nakamura | K. Imai | Takashi Yoshida | T. Yamaya